Lidia Brownell
Papers
1
Total Citations
15
H-Index
1
About
Dr. Lidia Brownell is a pioneering pharmacologist whose research bridges natural product discovery and gastrointestinal neurobiology. Her work centers on the molecular mechanisms of cholecystokinin (CCK) signaling, particularly through the CCK1 receptor, which regulates digestion and satiety. In her landmark 2010 study, "Screening a Plant Extract Library for Inhibitors of Cholecystokinin Receptor CCK1 Pathways," Dr. Brownell developed a high-throughput screening method to identify plant-derived compounds that modulate CCK1 activity—a critical step toward novel treatments for obesity, metabolic disorders, and digestive dysfunction. This foundational work, cited 15 times, established a framework for exploring how botanical extracts can selectively target GPCR pathways, opening new avenues for drug discovery from natural sources. Her contributions have been recognized for their translational potential, combining rigorous pharmacological validation with ethnobotanical knowledge. Dr. Brownell’s research continues to inspire investigations into receptor-specific therapeutics, demonstrating how traditional remedies can be systematically evaluated for modern biomedical applications. Her work remains essential reading for researchers in neurogastroenterology and natural product pharmacology.
Research Focus
Key Achievements
Top Papers
- 1